Human Genome Epidemiology Literature Finder
|
Records 1 - 14 (of 14 Records) |
| Query Trace: Death and SMARCA4[original query] |
|---|
| Genotype-phenotype correlation of Coffin-Siris syndrome caused by mutations in SMARCB1, SMARCA4, SMARCE1, and ARID1A. American journal of medical genetics. Part C, Seminars in medical genetics 2014 Sep 166C (3): 262-75. Kosho Tomoki, Okamoto Nobuhiko, |
| Variants in the SMARCA4 gene was associated with coronary heart disease susceptibility in Chinese han population. Oncotarget 2016 Dec . Guo Xuan, Wang Xiaohong, Wang Yuan, Zhang Chunyan, Quan Xiaohui, Zhang Yan, Jia Shan, Ma Weidong, Fan Yajie, Wang Congx |
| KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden. Annals of oncology : official journal of the European Society for Medical Oncology 2020 Aug . Marinelli D, Mazzotta M, Scalera S, Terrenato I, Sperati F, D'Ambrosio L, Pallocca M, Corleone G, Krasniqi E, Pizzuti L, Barba M, Carpano S, Vici P, Filetti M, Giusti R, Vecchione A, Occhipinti M, Gelibter A, Botticelli A, De Nicola F, Ciuffreda L, Goeman F, Gallo E, Visca P, Pescarmona E, Fanciulli M, De Maria R, Marchetti P, Ciliberto G, Maugeri-Saccà |
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
| Comprehensive characterization of distinct genetic alterations in metastatic breast cancer across various metastatic sites. NPJ breast cancer 2021 Jul 7 (1): 93. Cha Soojin, Lee Esak, Won Hong-H |
| SWI/SNF chromatin remodeling complex alterations in meningioma. Journal of cancer research and clinical oncology 2021 Mar . Gill Corey M, Loewenstern Joshua, Rutland John W, Arib Hanane, Pain Margaret, Umphlett Melissa, Kinoshita Yayoi, McBride Russell B, Bederson Joshua, Donovan Michael, Sebra Robert, Fowkes Mary, Shrivastava Raj |
| Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer. Thoracic cancer 2022 Sep . Chang Geyun, Li Weihua, Bai Hua, Duan Jianchun, Wang Zhijie, Du Xinyang, Yu Ruofei, Wang Yaxi, Wang Minghao, Zhu Yixiang, Zhang Xue, Li Li, Wan Rui, Wang J |
| Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC. JTO clinical and research reports 2022 Sep 3 (9): 100390. Cooper Alissa J, Muzikansky Alona, Lennerz Jochen, Narinesingh Farhaana, Mino-Kenudson Mari, Hung Yin P, Piotrowska Zofia, Dagogo-Jack Ibiayi, Sequist Lecia V, Gainor Justin F, Lin Jessica J, Heist Rebecca |
| Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Deficient Thoracic Tumor. Clinical lung cancer 2022 5 23 (5): 386-392. Shinno Yuki, Yoshida Akihiko, Masuda Ken, Matsumoto Yuji, Okuma Yusuke, Yoshida Tastuya, Goto Yasushi, Horinouchi Hidehito, Yamamoto Noboru, Yatabe Yasushi, Ohe Yuichi |
| A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer. Frontiers in medicine 2022 9 808378. Peng Jie, Xiao Lushan, Zou Dan, Han Lij |
| Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer 2022 Jun . Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam |
| [Evaluation of Efficacy and Prognosis Analysis of Stage III-IV SMARCA4-deficient ?Non-small Cell Lung Cancer Treated by PD-1 Immune Checkpoint Inhibitors plus ?Chemotherapy and Chemotherapy]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2023 11 26 (9): 659-668. Xinjuan Wang, Meng Tu, Hongxia Jia, Hongping Liu, Yan Wang, Yibo Wang, Nan Jiang, Chunya Lu, Guojun Zha |
| STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status. Lung cancer (Amsterdam, Netherlands) 2024 12 199 108058. Andrea De Giglio, Dario De Biase, Valentina Favorito, Thais Maloberti, Alessandro Di Federico, Federico Zacchini, Giulia Venturi, Claudia Parisi, Filippo Gustavo Dall'Olio, Ilaria Ricciotti, Ambrogio Gagliano, Barbara Melotti, Francesca Sperandi, Annalisa Altimari, Elisa Gruppioni, Giovanni Tallini, Francesco Gelsomino, Lorenzo Montanaro, Andrea Ardizzo |
| Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study. BMC medicine 2024 12 22 (1): 585. Xue Zhang, Xin Dai, Aina Liu, Meili Sun, Lei Cong, Jing Liang, Zimin Liu, Zhen Li, Jinling Zhang, Jing Lv, Fangli Cao, Linli Qu, Haiyan Liu, Lu Yue, Yi Zhai, Fujun Yang, Jiahui Chu, Shuang Wang, Qian Xu, Jianyuan Zhou, Shulun Nie, Miao Huang, Ruitao Xu, Qiushi Wang, Xinyu Song, Di Zhang, Zhaodi Nan, Song Li, Lian L |
- Page last reviewed:Feb 1, 2024
- Content source: